IR@PKUHSC  > 北京大学药学院  > 药剂学系
学科主题药学
A mechanism-based pharmacokinetic/pharmacodynamic model for CYP3A1/2 induction by dexamethasone in rats
Li, Liang2; Li, Zai-quan3; Deng, Chen-hui2; Ning, Miao-ran2; Li, Han-qing2; Bi, Shan-shan2; Zhou, Tian-yan1,2; Lu, Wei1,2
关键词Drug-drug Interactions Dexamethasone Cyp Induction Cyp3a1/2 Pharmacokinetics Pharmacodynamics Nonmem
刊名ACTA PHARMACOLOGICA SINICA
2012
DOI10.1038/aps.2011.161
33期:1页:127-136
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Chemistry, Multidisciplinary ; Pharmacology & Pharmacy
研究领域[WOS]Chemistry ; Pharmacology & Pharmacy
关键词[WOS]VS. SEQUENTIAL-ANALYSIS ; PREGNANE X RECEPTOR ; IN-VITRO ; LIVER-MICROSOMES ; FEMALE RATS ; PHARMACOKINETICS ; METABOLISM ; EXPRESSION ; TOXICITY ; HEPATOCYTES
英文摘要

Aim: To develop a pharmacokinetic/pharmacodynamic (PK/PD) model describing the receptor/gene-mediated induction of CYP3A1/2 by dexamethasone (DEX) in rats.

Methods: A group of male Sprague-Dawley rats receiving DEX (100 mg/kg, ip) were sacrificed at various time points up to 60 h post-treatment. Their blood sample and liver were collected. The plasma concentration of DEX was determined with a reverse phase HPLC method. CYP3A1/2 mRNA, protein levels and enzyme activity were measured using RT-PCR, Elisa and the testosterone substrate assay, respectively. Data analyses were performed using a first-order conditional estimate (FOCE) with INTERACTION method in NON-MEM version 7.1.2.

Results: A two-compartment model with zero-order absorption was applied to describe the pharmacokinetic characteristics of DEX. Systemic clearance, the apparent volume of distribution and the duration of zero-order absorption were calculated to be 172.7 mL.kg(-1).h(-1), 657.4 mL/kg and 10.47 h, respectively. An indirect response model with a series of transit compartments was developed to describe the induction of CYP3A1/2 via PXR transactivation by DEX. The maximum induction of CYP3A1 and CYP3A2 mRNA levels was achieved, showing nearly 21.29- and 8.67-fold increases relative to the basal levels, respectively. The CYP3A1 and CYP3A2 protein levels were increased by 8.02-fold and 2.49-fold, respectively. The total enzyme activities of CYP3A1/2 were shown to increase by up to 2.79-fold, with a lag time of 40 h from the Tmax of the DEX plasma concentration. The final PK/PD model was able to recapitulate the delayed induction of CYP3A1/2 mRNA, protein and enzyme activity by DEX.

Conclusion: A mechanism-based PK/PD model was developed to characterize the complex concentration-induction response relationship between DEX and CYP3A1/2 and to resolve the drug-and system-specific PK/PD parameters for the course of induction.

语种英语
WOS记录号WOS:000299213100018
引用统计
被引频次:12[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/58170
专题北京大学药学院_药剂学系
北京大学医学部管理机构_医学部
作者单位1.Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China
2.Peking Univ, Hlth Sci Ctr, Sch Pharmaceut Sci, Dept Pharmaceut, Beijing 100191, Peoples R China
3.Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Radiat Med, Beijing 100191, Peoples R China
推荐引用方式
GB/T 7714
Li, Liang,Li, Zai-quan,Deng, Chen-hui,et al. A mechanism-based pharmacokinetic/pharmacodynamic model for CYP3A1/2 induction by dexamethasone in rats[J]. ACTA PHARMACOLOGICA SINICA,2012,33(1):127-136.
APA Li, Liang.,Li, Zai-quan.,Deng, Chen-hui.,Ning, Miao-ran.,Li, Han-qing.,...&Lu, Wei.(2012).A mechanism-based pharmacokinetic/pharmacodynamic model for CYP3A1/2 induction by dexamethasone in rats.ACTA PHARMACOLOGICA SINICA,33(1),127-136.
MLA Li, Liang,et al."A mechanism-based pharmacokinetic/pharmacodynamic model for CYP3A1/2 induction by dexamethasone in rats".ACTA PHARMACOLOGICA SINICA 33.1(2012):127-136.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Li, Liang]的文章
[Li, Zai-quan]的文章
[Deng, Chen-hui]的文章
百度学术
百度学术中相似的文章
[Li, Liang]的文章
[Li, Zai-quan]的文章
[Deng, Chen-hui]的文章
必应学术
必应学术中相似的文章
[Li, Liang]的文章
[Li, Zai-quan]的文章
[Deng, Chen-hui]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。